UGT71D2 Antibody

What is UGT71D2 and how does it fit into the broader UGT enzyme family classification?

UGT71D2 belongs to the UGT71 subfamily within glycosyltransferase Group E (which includes UGT71/72/88 enzymes). These enzymes are part of a larger evolutionary family of glycosyltransferases that have undergone significant functional divergence. The UGT71 subfamily is specifically positioned within key phylogenetic group E, as established through comprehensive evolutionary analysis . The standard nomenclature for UDP-glucuronosyltransferases follows specific patterns, with UGT71 representing a distinct plant-specific subfamily that diverged from other UGT groups during evolution. It's important to note that this enzyme is distinct from the better-studied mammalian UGT1A subfamily commonly involved in drug metabolism .

How does UGT71D2 differ functionally from other closely related glycosyltransferases?

UGT71D2, like other members of the UGT71 family, demonstrates substrate specificity that differs from related glycosyltransferases. Research indicates that enzymes within the same phylogenetic cluster can exhibit divergent substrate selectivity. For instance, while some UGT enzymes in Group G (such as UGT85A53 and UGT1) show preference for volatile compounds like geraniol and β-citronellol, they differ in their ability to glycosylate non-volatile compounds such as plant hormones . Similar functional divergence likely exists within the UGT71 subfamily, where duplicated gene pairs may maintain common substrates while developing unique specificities for other compounds. This functional divergence appears to be a common evolutionary pattern among glycosyltransferases and likely applies to UGT71D2's relationship with its closest phylogenetic neighbors .

What are the recommended validation methods to confirm UGT71D2 antibody specificity?

Validating UGT71D2 antibody specificity requires a multi-dimensional approach. Begin with western blotting against recombinant UGT71D2 protein alongside related UGT family members to establish cross-reactivity profiles. Implement knockout/knockdown controls where the target protein is absent to confirm signal specificity. For advanced validation, epitope mapping techniques similar to those used for other autoantibodies can be employed to characterize exact binding sites . Additionally, immunoprecipitation followed by mass spectrometry analysis provides definitive confirmation of antibody-target interaction. Validation should include testing across multiple tissue types where the enzyme is expressed at different levels to establish detection thresholds and rule out non-specific binding. Documentation of validation experiments should include positive and negative controls, with quantitative analysis of signal-to-noise ratios .

How can researchers distinguish between UGT71D2 and closely related UGT family members when using antibodies?

Distinguishing between UGT71D2 and closely related family members requires careful antibody selection and validation protocols. First, perform sequence alignment analysis of the UGT71 subfamily to identify unique epitopes specific to UGT71D2. These regions, typically in non-conserved loops or C-terminal domains, should be targeted for antibody development. Implement competitive binding assays where recombinant proteins from related UGT subfamilies are used to determine cross-reactivity profiles . For quantitative discrimination, establish optimal cut-off values using chi-squared statistical maximization approaches as demonstrated in antibody selection studies . This method involves sorting antibody response values in increasing order and calculating the chi-squared statistic for each potential cut-off to determine the value that provides maximum discrimination. Advanced researchers should consider developing a panel of antibodies targeting different epitopes of UGT71D2 to create a signature recognition pattern that enhances specificity .

What are the optimal conditions for using UGT71D2 antibodies in immunoprecipitation experiments?

For optimal immunoprecipitation of UGT71D2, begin with appropriate buffer composition: 50mM Tris-HCl (pH 7.4), 150mM NaCl, 1% NP-40 or 0.03% Proclin 300, with 50% glycerol for antibody stability. Include protease inhibitors to prevent target degradation. The antibody-to-lysate ratio should be optimized through titration experiments, typically starting with 2-5μg antibody per 500μg total protein. Pre-clear lysates with protein A/G beads for 1 hour at 4°C to reduce non-specific binding. For membrane-associated UGTs like UGT71D2, add 0.1% SDS to improve solubilization while maintaining protein-antibody interactions. Incubate antibody-lysate mixture overnight at 4°C with gentle rotation to maximize binding while preserving antibody activity. Wash stringently (at least 4-5 times) with decreasing salt concentrations to remove non-specific interactions while preserving specific binding. Elution can be performed using either acidic conditions (0.1M glycine, pH 2.5) or by boiling in SDS sample buffer, depending on downstream applications.

How can UGT71D2 antibodies be optimized for immunohistochemistry in plant tissue sections?

Optimizing UGT71D2 antibodies for plant tissue immunohistochemistry requires specific adaptations to address cell wall barriers and fixation challenges. Begin with appropriate fixation using 4% paraformaldehyde in PBS for 24 hours, followed by paraffin embedding. For antigen retrieval, employ enzymatic methods using a combination of cellulase (1%) and pectinase (0.5%) in citrate buffer (pH 6.0) at 37°C for 30 minutes to break down cell wall components while preserving epitope structures. Block with 5% BSA supplemented with 0.3% Triton X-100 in PBS for 2 hours at room temperature to reduce non-specific binding. The primary antibody dilution requires careful titration, typically starting at 1:100-1:500 in blocking buffer with overnight incubation at 4°C. For signal amplification in tissues with low UGT71D2 expression, implement tyramide signal amplification systems, which can enhance detection sensitivity up to 100-fold while maintaining specificity. Include appropriate controls: primary antibody omission, pre-immune serum substitution, and comparative staining with tissues known to have differential UGT71D2 expression levels .

How can researchers determine the substrate specificity of UGT71D2 using antibody-based approaches?

Determining UGT71D2 substrate specificity through antibody-based approaches requires a strategic combination of immunocapture and activity assays. First, use purified UGT71D2 antibodies to immunoprecipitate the native enzyme from plant extracts. The captured enzyme can then be incubated with a panel of potential substrates (including volatiles like geraniol and β-citronellol, as well as plant hormones) in the presence of UDP-glucose as a sugar donor . Product formation can be analyzed using liquid chromatography-mass spectrometry (LC-MS/MS) to identify glycosylated products. Quantification of reaction rates can be achieved by measuring either the formation of glycosylated products or the release of free UDP .

For comparative analysis, create a substrate preference profile table:

*Values shown are representative based on related UGT enzyme studies and would need to be specifically determined for UGT71D2.

For advanced analysis, develop a competitive substrate assay where multiple substrates are present simultaneously, allowing direct comparison of substrate preference under identical conditions .

What methods are available to assess the kinetic parameters of UGT71D2 enzymatic activity?

Assessment of UGT71D2 kinetic parameters requires sophisticated enzymatic assays that can be enhanced with antibody-based detection methods. Begin by immunoprecipitating UGT71D2 from plant tissues or expressing it recombinantly with appropriate tags for purification. For kinetic analysis, utilize a UDP-Glo assay to quantify free UDP release as a direct measurement of glycosylation activity. This luminescence-based approach offers high sensitivity and a broad dynamic range .

To determine kinetic parameters, perform substrate saturation experiments with varying concentrations of potential substrates (typical range: 0.1-2000 μM) while maintaining constant UDP-glucose concentration. For each substrate, measure initial velocities and fit the data to Michaelis-Menten, Hill, or substrate inhibition models as appropriate. Calculate Km, Vmax, and kcat values to characterize substrate affinity and catalytic efficiency.

For complex analyses, utilize progress curve analysis with global fitting algorithms to simultaneously determine both forward and reverse reaction parameters. This approach captures the complete kinetic profile including potential product inhibition. For multisubstrate reactions, implement bisubstrate kinetic models to determine binding order and potential cooperative effects between UDP-glucose and acceptor substrate binding sites. Advanced researchers should consider isothermal titration calorimetry (ITC) to directly measure binding energetics and differentiate between binding and catalytic events .

How does UGT71D2 expression change under different stress conditions in plant systems?

UGT71D2 expression exhibits dynamic regulation in response to various abiotic stresses, similar to other UGT family members. Analysis of duplication patterns and expression profiles suggests that genes within the same phylogenetic clusters often show divergent responses to stress conditions. For instance, related UGT enzymes in the G group (UGT85A53 and UGT1) demonstrate opposite expression patterns under cold and drought stress conditions .

A comprehensive expression analysis would reveal how UGT71D2 responds to various environmental challenges:

*Expression patterns predicted based on related UGT enzyme studies and would need to be specifically determined for UGT71D2.

For mechanistic insights, chromatin immunoprecipitation (ChIP) analysis can identify transcription factors that bind to the UGT71D2 promoter under different stress conditions, elucidating the regulatory networks controlling its expression. Promoter analysis should focus on identifying stress-responsive elements that mediate these transcriptional changes .

What techniques are most effective for studying the subcellular localization of UGT71D2?

Studying UGT71D2 subcellular localization requires a multi-faceted approach combining antibody-based detection with complementary techniques. For immunofluorescence microscopy, use affinity-purified UGT71D2 antibodies with appropriate fixation protocols (4% paraformaldehyde for protein crosslinking while preserving cellular architecture). Counterstain with established organelle markers such as BiP (ER), ST-GFP (Golgi), or γ-TIP (vacuole) to precisely determine co-localization .

For biochemical validation, implement subcellular fractionation followed by western blotting with UGT71D2 antibodies. This approach provides quantitative distribution across cellular compartments and should include marker proteins for each fraction as internal controls. Advanced techniques include proximity labeling methods such as APEX2 or BioID fused to UGT71D2, which biotinylate proteins in close proximity (within 10-20nm), allowing identification of the spatial environment and potential interaction partners.

For highest resolution analysis, employ immuno-electron microscopy using gold-conjugated secondary antibodies against UGT71D2 primary antibodies. This technique provides nanometer-scale resolution of protein localization within cellular ultrastructure. Live-cell imaging can be performed using split-GFP complementation, where UGT71D2 is fused to one GFP fragment and known organelle proteins to the complementary fragment. Fluorescence only occurs when both fragments are in close proximity, confirming co-localization in living cells without fixation artifacts .

What molecular techniques are recommended for identifying UGT71D2 gene variants and studying their functional impact?

Identifying UGT71D2 variants requires a comprehensive genomic approach combined with functional characterization. Begin with amplicon sequencing of the UGT71D2 coding region from diverse plant accessions or species to identify natural variants. For capturing the complete spectrum of variations, whole-genome sequencing followed by targeted analysis of the UGT71D2 locus and regulatory regions is recommended. Variants should be categorized as coding (missense, nonsense, frameshift) or non-coding (promoter, UTR, intronic) to predict their potential impact .

For functional analysis, express recombinant variants and assess enzyme activity using the substrate panel established in previous assays. Key parameters to compare include:

For analyzing the structural impact of variants, implement molecular modeling based on crystal structures of related UGT enzymes. This approach can predict how specific amino acid substitutions might alter substrate binding pockets or catalytic sites. For critical variants, X-ray crystallography or cryo-EM studies would provide definitive structural insights .

How can CRISPR-Cas9 gene editing be optimized for studying UGT71D2 function in plant systems?

Optimizing CRISPR-Cas9 gene editing for UGT71D2 functional studies requires careful design and validation strategies. Begin by selecting multiple guide RNAs (gRNAs) targeting conserved catalytic domains of UGT71D2, preferably within the first half of the coding sequence. Design should account for plant codon optimization and specific PAM requirements of the selected Cas9 variant. Implement in silico analysis to predict off-target effects, particularly on closely related UGT family members that share sequence homology .

For delivery into plant systems, Agrobacterium-mediated transformation typically provides efficient integration. In species recalcitrant to Agrobacterium, consider direct DNA delivery methods such as biolistics or protoplast transfection. After transformation, implement a tiered screening approach:

• PCR-based genotyping to identify potential editing events

• Sanger sequencing to confirm precise mutations

• Whole-genome sequencing for a subset of lines to assess off-target effects

• qRT-PCR and western blotting to confirm knockout efficiency at mRNA and protein levels

For functional characterization, key phenotypic analyses should include:

For studying essential genes where knockout may be lethal, implement conditional editing systems such as inducible CRISPR or tissue-specific promoters. Creating precise point mutations rather than knockouts can provide nuanced understanding of specific amino acid contributions to enzyme function .

How does UGT71D2 compare to UGT71 family members across different plant species?

UGT71D2 shows significant evolutionary diversity across plant species, reflecting adaptation to different ecological niches and metabolic requirements. Phylogenetic analysis places UGT71D2 within Group E of the glycosyltransferase superfamily, alongside other UGT71/72/88 family members . Comparative genomic analysis reveals that UGT71 genes have undergone lineage-specific expansions in various plant families, with evidence of both tandem and whole-genome duplication events contributing to functional diversification.

Sequence alignment of UGT71 homologs across species demonstrates conservation of key catalytic domains while showing divergence in substrate-binding regions. The Plant Secondary Product Glycosyltransferase (PSPG) motif, crucial for UDP-sugar recognition, maintains high conservation across species, while the N-terminal region exhibits greater variability, likely reflecting adaptation to different substrate profiles .

Functional comparisons indicate that UGT71 enzymes across species maintain core glycosylation activity but have evolved distinct substrate preferences. For instance:

*Based on comparative analysis of related UGT71 family members

Evolutionary rate analysis of UGT71 family members demonstrates episodes of positive selection following gene duplication events, suggesting adaptive evolution in response to changing metabolic requirements or environmental pressures .

What bioinformatic approaches are most effective for analyzing UGT71D2 in the context of glycosyltransferase evolution?

Effective bioinformatic analysis of UGT71D2 within glycosyltransferase evolution requires an integrated computational strategy. Begin with comprehensive sequence retrieval from genomic databases, ensuring coverage across major plant lineages. Multiple sequence alignment should employ structure-aware algorithms such as MAFFT or MUSCLE, with manual curation of alignments focused on catalytic domains and substrate-binding regions .

For phylogenetic reconstruction, implement a maximum likelihood approach using models that account for site-specific evolutionary rates (e.g., LG+G+I+F). Tree topology should be validated through bootstrap analysis (>1000 replicates) and Bayesian inference to ensure robust evolutionary hypotheses .

For structure-function relationships, implement homology modeling based on crystal structures of related UGTs. Key analyses include:

For gene duplication analysis, implement reconciliation of gene and species trees to differentiate between orthologs and paralogs. Synteny analysis across genomes can reveal the chromosomal context of duplication events and subsequent rearrangements. Complementary transcriptomic data analysis can identify expression divergence following duplication, providing insights into subfunctionalization or neofunctionalization processes .

How can antibodies against UGT71D2 be utilized in high-throughput screening of enzyme inhibitors or activators?

Utilizing UGT71D2 antibodies for high-throughput screening requires development of robust immunoassay platforms adaptable to automated systems. Begin by establishing a capture-based enzyme activity assay where anti-UGT71D2 antibodies immobilized on microplates capture the enzyme from plant extracts or recombinant sources. The captured enzyme maintains catalytic activity, allowing screening of compounds that modulate this activity .

For primary screening, implement a fluorescence-based assay using UDP-glucosyltransferase activity. Design a UDP-glucose analog with a fluorescent tag that transfers to the substrate, generating a measurable signal. Alternatively, employ a coupled enzyme assay where UDP released during glycosylation drives a secondary reaction with measurable output. This approach allows screening of compound libraries in 384- or 1536-well formats .

For advanced screening cascades, include counter-screens and confirmatory assays:

Implementation of this screening workflow would enable identification of selective UGT71D2 modulators with potential applications in controlling glycoside formation in plants. The antibody-based capture approach ensures specificity while maintaining native enzyme conformation and activity .

What are the emerging research directions in understanding the role of UGT71D2 in plant secondary metabolism and stress response?

Emerging research on UGT71D2 and related glycosyltransferases is revealing their critical roles in plant secondary metabolism and stress adaptation. Future research directions are focusing on several frontier areas:

• Metabolic network integration: Employing systems biology approaches to position UGT71D2 within comprehensive metabolic networks. This includes flux analysis using isotope labeling to track carbon flow through glycosylation pathways and identifying metabolic bottlenecks where UGT71D2 activity becomes rate-limiting .

• Stress signaling crosstalk: Investigating how UGT71D2-mediated glycosylation interfaces with multiple stress response pathways. Evidence from related UGTs suggests that glycosylation of signaling molecules can modulate their activity, stability, and cellular localization .

• Climate adaptation mechanisms: Examining how UGT71D2 expression and activity patterns correlate with plant adaptation to changing environmental conditions. This includes studying natural variation in UGT71D2 across ecological gradients to identify adaptive alleles .

• Novel substrate discovery: Implementing untargeted metabolomics approaches to identify the complete substrate spectrum of UGT71D2. This would involve comparative analysis of metabolite profiles in wild-type versus UGT71D2 knockout/overexpression lines under various conditions .

• Protein-protein interaction networks: Identifying UGT71D2 interacting partners that may modulate its activity or specificity. Evidence from other glycosyltransferases suggests they may function in metabolic complexes or "metabolons" that enhance pathway efficiency .

• Translational applications: Exploring how manipulation of UGT71D2 activity could enhance crop resilience to environmental stresses or improve production of valuable plant-derived compounds. This includes potential biotechnological applications in metabolic engineering of medicinal plants or food crops .

These research directions represent cutting-edge approaches to understanding the multifaceted roles of UGT71D2 in plant biology and its potential applications in agriculture and biotechnology.

What are the common technical challenges when working with UGT71D2 antibodies and how can they be addressed?

Working with UGT71D2 antibodies presents several technical challenges that require systematic troubleshooting approaches. Common issues and their solutions include:

• Cross-reactivity with related UGT enzymes: Due to sequence homology within the UGT71 family, antibodies may recognize multiple related enzymes. To address this, implement epitope mapping to identify unique regions of UGT71D2, and use affinity purification against these specific peptides to isolate antibodies with highest specificity . Pre-absorption with recombinant related UGTs can also remove cross-reactive antibodies from polyclonal preparations.

• Weak signal in plant tissue samples: UGT71D2 may be expressed at low levels in some tissues. Enhance detection by implementing signal amplification systems such as tyramide signal amplification or polymer-based detection systems. Optimizing antigen retrieval protocols is critical, particularly for plant tissues where cell wall components can mask epitopes .

• Batch-to-batch variability in antibody performance: To mitigate this issue, establish comprehensive validation protocols for each new antibody lot, including western blotting against recombinant standards and known positive/negative tissue samples. Maintain reference standards and established positive controls for consistent comparison across experiments.

• Non-specific background in immunohistochemistry: Plant tissues often contain compounds that contribute to background staining. Address this by implementing extended blocking steps (2-3 hours) with 5% BSA supplemented with 0.3% Triton X-100. Additional blocking with 10% normal serum matching the secondary antibody host species can further reduce background. For tissues with high autofluorescence, implement spectral unmixing during imaging or use non-fluorescent detection methods .

• Antibody stability and storage issues: Maintain antibody activity by storing in appropriate buffer conditions (50% glycerol, PBS pH 7.4, 0.03% Proclin 300) at recommended temperatures (-20°C for long-term). Avoid repeated freeze-thaw cycles by preparing single-use aliquots. Monitor antibody performance over time with regular validation assays to detect potential degradation.

How can conflicting results in UGT71D2 research be reconciled through methodological optimization?

Reconciling conflicting results in UGT71D2 research requires methodological standardization and critical evaluation of experimental approaches. Several strategies can address common sources of discrepancy:

• Antibody validation discrepancies: Different studies may use antibodies with varying specificities, leading to contradictory results. Implement a multi-approach validation framework that includes western blotting, immunoprecipitation followed by mass spectrometry, and testing in knockout/knockdown systems. Document and report validation metrics quantitatively, such as signal-to-noise ratios and cross-reactivity profiles with homologous proteins .

• Substrate specificity inconsistencies: Conflicting reports on substrate preferences may arise from differences in assay conditions. Standardize enzyme activity assays by controlling critical parameters including pH, temperature, cofactor concentrations, and enzyme-to-substrate ratios. Implement multiparametric optimization using design of experiments (DoE) approaches to identify optimal conditions that maximize assay reproducibility .

• Expression pattern discrepancies: Different studies may report varied expression patterns depending on growth conditions or developmental stages. Address this by implementing time-course studies with standardized growth conditions and precise developmental staging. Normalize expression data to multiple reference genes validated for stability across the experimental conditions .

• Conflicting phenotypic observations in genetic studies: Differences in genetic backgrounds can lead to variable phenotypes in knockout/overexpression studies. Implement the same genetic manipulation in multiple backgrounds, and use complementation studies to confirm phenotype attribution. Consider the potential for genetic redundancy and compensation by related UGT family members .

• Statistical analysis and data presentation: Implement robust statistical approaches appropriate for the data type, avoiding p-hacking through multiple testing without correction. For borderline significant results, increase biological replicates to enhance statistical power. Promote transparency by providing raw data and detailed methodological descriptions to enable reproducibility .

By systematically addressing these methodological considerations, researchers can reconcile conflicting results and establish a more coherent understanding of UGT71D2 function and regulation in plant systems.